EP2473510
JAK2 tálmar og notkun þeirra við meðferð á fjölgandi mergsjúkdómum og krabbameini
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
2.9.2010EP published:
23.7.2014EP application number:
10757878.3
EP translation filed:
29.8.2014Grant published:
15.9.2014EPO information:
European Patent Register
Max expiry date:
1.9.2030Expiry date:
1.9.2023
Title:
JAK2 INHIBITORS AND THEIR USE FOR THE TREATMENT OF MYELOPROLIFERATIVE DISEASES AND CANCER
Timeline
Today
2.9.2010EP application
23.7.2014EP Publication
29.8.2014Translation submitted
15.9.2014Registration published
1.9.2023Expires
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, 08543, Princeton, NJ, US
Inventor
Name:
PURANDARE, Ashok V.Address:
Princeton, New Jersey, US
Name:
GREBINSKI,James W.Address:
Princeton, New Jersey, US
Name:
HART, AmyAddress:
Princeton, New Jersey, US
Name:
INGHRIM, JenniferAddress:
Princeton, New Jersey, US
Name:
SCHROEDER, GretchenAddress:
Princeton, New Jersey, US
Name:
WAN, HongheAddress:
Princeton, New Jersey, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
239501 PDate:
3.9.2009Country:
US
Classification
Categories:
C07D 471/14, A61K 31/437, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 27.8.2014
Expires: 1.9.2015
Payer: Árnason Faktor
Number: 6
Paid: 6.8.2015
Expires: 1.9.2016
Payer: Árnason Faktor
Number: 7
Paid: 8.8.2016
Expires: 1.9.2017
Payer: Árnason Faktor
Number: 8
Paid: 9.8.2017
Expires: 1.9.2018
Payer: Árnason Faktor
Number: 9
Paid: 8.8.2018
Expires: 1.9.2019
Payer: Árnason Faktor
Number: 10
Paid: 7.8.2019
Expires: 1.9.2020
Payer: Árnason Faktor
Number: 11
Paid: 6.8.2020
Expires: 1.9.2021
Payer: Árnason Faktor ehf.
Number: 12
Paid: 10.8.2021
Expires: 1.9.2022
Payer: Árnason Faktor ehf.
Number: 13
Paid: 16.8.2022
Expires: 1.9.2023
Payer: Árnason Faktor ehf.